Peripheral blood mononuclear cells (PBMC) from three adult male squirrel monkeys (SaõF miri sciureus) were transformed by human T-cell leukemia/lymphoma virus type I (HTLV-I) by cocultivation with lethally irradiated human MT-2 cells. Three permanent monkey T-cell lines producing HTLV-I were obtained and characterized. Six weeks after inoculation seroconversion was observed in three of three monkeys inoculated with autologous transformed T cells and in two of three monkeys receiving homologous cells. Proviral DNA was detected in their PBMC at various times after inoculation, with the highest proviral load and antibody titers being found in monkeys infected with homologous cells. Monkeys inoculated with heterologous MT-2 cells did not seroconvert, and HTLV-I provirus was detected only transiently in their PBMC. To determine whether in vitro and in vivo HTLV
.
The aim of the present work was to study further experAnimal models of infection with human T-cell leukeimental HTLV-I infection of the squirrel monkey (SaõF miri mia/lymphoma virus type I (HTLV-I) are most useful for sciureus), a New World species that is free of simian Tstudying host-virus interactions and the pathogenesis cell leukemia/lymphoma viruses (STLVs), and to test it of associated diseases, such as adult T-cell leukemia as a possible experimental model for pathogenesis and (Poiesz et al., 1980; Yoshida et al., 1984) and tropical vaccine development. Nakamura et al. (1986) tested the spastic paraparesis/HTLV-I-associated myelopathy susceptibility of squirrel monkeys to HTLV-I infection by (Gessain et al., 1985) . They are also essential for testing inoculation with autologous (syngeneic) cells transcandidate vaccines (Bomford et al., 1996; formed by HTLV-I. We have compared the efficacy of Kazanji, 1996) . Chronic HTLV-I infections have been inautologous (syngeneic), homologous (allogeneic), and duced in both the rabbit (Miyoshi et al., 1985; Cockerell heterologous (xenogeneic) HTLV-I-transformed cells to et al., 1990; Lairmore et al., 1992) and the rat (Yoshiki et infect squirrel monkeys with HTLV-I. The correlation beal., 1987; Suga et al., 1991; Ishiguro et al., 1992;  Ibrahim tween the proviral load and the immune response was et al., 1994) . also investigated. Finally, we assessed the genomic staSeveral species of nonhuman primates have also been bility of HTLV-I after inoculation into a nonnatural host, found to be susceptible to infection by HTLV-I. Marmoto determine whether HTLV-I infection in the squirrel sets (Callithrix jacchus) were infected orally by the milk monkey is accompanied by selection of monkey-adapted of HTLV-I-carrying women (Yamanouchi et al., 1985) . Cyviral mutants. nomolgus macaques (Macaca fascicularis) and pig-tailed macaques (Macaca nemestrina) were protected against MATERIALS AND METHODS amination confirmed that the animals were free of STLV monkey cell lines. The cells were then fixed and stained with 5-bromo-4-chloro-3-indolyl b-D-galactoand HTLV-I/II (data not shown). Moreover, high-molecular-weight DNA was extracted from the peripheral blood pyranoside (X-gal) for up to 4 hr. Blue spots revealed fusion between the P4 cells, the HTLV-I env expressing mononuclear cells (PBMCs) of all the monkeys before inoculation and PCR was done by using primers Env1-cells, and the cell line producing Tat. Env22, which were shown to amplify all the different Inoculation of monkeys with HTLV-I-producing cells HTLV-I/STLV-I subtypes (Koralnik et al., 1994) . Polymerase chain reaction (PCR) products were then transferred Three monkeys were inoculated intravenously with 10 8 and membranes hybridized with specific probes. autologous HTLV-I-transformed producing cells, three In order to immortalize monkey cells lines with HTLVfurther monkeys with 10 7 homologous HTLV-I-producing I, 10 6 PBMCs from the three monkeys were cocultivated monkey cell lines, and two monkeys with 10 7 heterolowith an equal number of lethally irradiated (10,000 rad) gous MT-2 cells. The protocol is summarized in Table 2 . MT-2 cells under the usual conditions: RPMI 1640 with Every 2 weeks after inoculation, blood samples were 20% heat-inactivated fetal calf serum, 1% L-glutamine and taken and each monkey was examined for visible signs 1% penicillin/streptomycin (Flow Labs, Scotland) suppleof lymphoid malignancy. mented with 20 U/ml of recombinant interleukin-2 (Boeh-HTLV-I antibodies in the serum of the inoculated monringer, Germany), with biweekly changes. keys were measured by ELISA (Diagnostic Biotechnology, Singapore) and confirmed by Western blot assay Immunovirological and molecular studies (HTLV-I; 2.3 Diagnostic Biotechnology). HTLV-I proviral copies in PBMC from infected monkeys were quantified To detect p19 and p24 viral antigen expression, an indirect immunofluorescence assay was performed on by the method described by Cimarelli et al. (1995) . Briefly, competitive PCR tests were performed on genomic DNA the cultured cells using either mouse monoclonal antibodies directed against these antigens (Cambridge Biopurified from PBMC of infected monkeys obtained 3, 6, and 12 months after inoculation. The number of HTLV-I tech, USA) or polyclonal sera from HTLV-I-infected individuals. FACS analysis (kindly performed by Dr. F. Vacopies was determined in 0.7 mg of DNA, corresponding to the amount of genomic DNA extracted from 10 5 PBMC. lensi, Hôpital Necker, Paris, France) of the cultured cells was undertaken with different monoclonal antibodies diTen months after inoculation, PBMC from the infected monkeys were cultured, and the supernatants were anarected against human T-cell and B-cell antigens, as previously described (Mahieux et al., 1994) . The production lyzed by an antigen capture assay (Retro-tek, HTLV p19 antigen ELISA; Cellular Products Inc., USA) that can deof p19 core antigen in the cultures supernatant was measured by a capture ELISA assay (Retro-tek HTLV p19 tect at least 25 pg/ml of the major core antigen gag p19 of HTLV-I. antigen ELISA, Cellular Products, USA) that detects HTLV-I, STLV-I, and HTLV-II p19.
Animals and transformation of monkey peripheral
Polymerase chain reaction High-molecular-weight DNA was extracted from the HTLV-I-transformed squirrel monkey cell lines. After diIn order to prevent PCR contamination, genomic DNA gestion by EcoRI restriction enzymes, the restricted fragwas extracted in the Pasteur Institute of French Guiana, ments were separated by electrophoresis, transferred to where HTLV-I has never been either amplified or cloned. nylon filters, and hybridized with either the PMT-3 subDuring PCR all steps were performed using positive discloned PstI fragment of the PMT-2 clone or the 1711 placement pipettes. The mixtures and the PCR were pertotal HTLV-I genomic probe (kindly provided by Dr. G.
formed by two different researchers in three different, Franchini, NIH, Bethesda, MD), as described by Gessain physically separate rooms. Two different negative PCR et al. (1992a) . controls were used for each experiment. PCR (35 cycles) or seminested PCR was performed on genomic DNA Syncitium formation assay extracted from PBMC or various organs, according to the method described by Ibrahim et al. (1994) . Single PCR As previously described by Clavel et al. (1994) , the syncitium formation assay involves HeLa-CD4 cells (P4 of the tax region (202 nucleotides) (Mahieux et al., 1995) involved the following primers: Rmtax1 (7784-7805), cells) carrying the bacterial lacZ gene under the control of the human immunodeficiency virus long terminal 5ACTAGAATTCGAACGGAAGGAGGCCGTTTTGC3 sense; and Rmtax2 (7964-7986), 5TTTGAGCGGCCG-repeat (Charneau et al., 1992) that these lines had monkey karyotypes (2n Å 44, data not shown). FACS analysis of the surface phenotypes of the lines showed them to be of T-cell lineage, with TGTCGTAGCTGCAGGAGG3 antisense; and env22 (6752-expression of CD2 and the activation marker HLA-DR but 6773), 5GGCGAGGTGGAGTCCTTGGAGGC3 antisense.
not B cell markers (Table 1 ). The amplified products were submitted to electrophoForty to sixty percent of cells of the three lines proresis on 1.4% agarose gel, transferred to nylon memduced HTLV-I p19 and p24 antigens detected by indirect branes, and hybridized with 32 P-labeled internal probes immunofluorescence assay (IFA). The proportion of posifor tax, probetax 5GGGGCCCTAATAATTCTACCCGAA-tive cells was always higher when a polyclonal HTLV-I GACT3, and for env, PE1-2 5CAGACGAGGCCTTGA-human serum was used than with the monoclonal anti TCTCCTGTT3.
p19, p24 antibodies. At 1 year of culture, 80% of the cells of the three transformed cell lines were positive by IFA Cloning and sequencing using a polyclonal HTLV-I human serum. Supernatants from the three lines were positive in the gag p19 antigen The cloning procedure was conducted in a laboratory capture assay, and the three cell lines induced syncytium where HTLV-I has never been amplified or cloned. The formation, indicating the presence of HTLV-I env at the PCR products were phosphorylated with T4 polynucleocell membranes. tide kinase and ligated with SmaI-digested and dephosSouthern blot analysis showed clonal integration of phorylated M13mp18 replicative form DNA. After trans-HTLV-I in the three cell lines, with at least one individual formation of Escherichia coli TG-1, recombinant plaques band migrating at a size greater than 9 kb (size of the were transferred in situ to nitrocellulose filters and screened by hybridization with the env-specific oligonucleotide PE1-2 (as described above). Filters were prehybridized at 42Њ for 1 hr in 41 SSC, 51 Denhardt, 0.5% SDS and then transferred to a fresh solution containing in addition the ognized only by antibodies present in the sera of the two monkeys inoculated with homologous transformed cells.
Detection of HTLV-I provirus by PCR
PBMC were obtained from all animals 1 year after inoculation. Tax sequences of HTLV-I provirus were detected by PCR in the PBMC from all monkeys inoculated with autologous cells and in two of the three monkeys inoculated with homologous cells (Fig. 4) . Note the apparently significant difference between monkeys inoculated with autologous cells (Fig. 4,  lanes a, b, and c ) and those infected with homologous cells (Fig. 4, lanes d and e) . In contrast, the HTLV-I provirus was detected in the PBMC of monkeys inoculated with MT-2 cells 3 weeks after inoculation but not at 3 months. These seronegative monkeys were killed 6 months after MT-2 injection, and no HTLV-I provirus was detected in any of the organs examined by PCR with tax and env primers, including heart, lung, liver, kidney, spleen, lymph nodes, and the central nervous system (results not shown).
One of the monkeys inoculated with autologous cells (monkey 798) died 6 months after inoculation of an acute renal failure which was clinically and pathologically proven. No evidence of hematological malignancy was 
Evolution of viral load and viral antigen production
As seen in Table 2 , the highest proviral load was found total HTLV-I provirus). The patterns of integration in these in the two monkeys inoculated with homologous HTLVcell lines were different from those observed with MT-2 I transformed cells, and the level remained stable over cells, suggesting the absence of surviving MT-2 cells in 12 months. The proviral load in the monkeys inoculated the cultures (Fig. 1 ). Viral particles with a diameter of with autologous cell lines remained very low but was 100-150 nm and a structure characteristic of HTLV-I detectable even 12 months after inoculation. were detected by electron microscopy in all three lines During 12 weeks of culture of PBMC from the serocon-(micrographs not shown).
verted monkeys, the supernatants were analyzed for Humoral responses of inoculated monkeys As seen in Fig. 2 , two of the three monkeys inoculated with homologous cells produced high antibody responses first detectable 6 weeks after cell inoculation and beginning to decline after 30-40 weeks. The three monkeys that received autologous cells developed a low titer of antibodies, and no HTLV-I antibodies were detected in the two monkeys inoculated with MT-2 cells, even after six months. As seen in Fig. 3 
HTLV-I p19 antigen. p19 was present continuously in
Quasi species and sequence analysis cultures from monkey 1491, which had been inoculated
Comparison of the sequences of proviral DNA correwith homologous cells (Fig. 5) , but was present only transponding to the carboxy terminus of the gp46 and the siently in the cultured PBMC obtained from the other inoculated monkeys. months after inoculation and those from the inoculated gether with high antibody titers, recalled the situation observed in human HTLV-I carriers (Cimarelli et al., 1995 ; homologous EVO/1540 cells and from MT-2 cells (Table  3) showed high similarity, with percentage of mutated Miyata et al., 1995) . Moreover, by using the same technique of competitive PCR, we have shown that the provisites of 0.10-0.28%. Neither the number of different mutations nor the number of mutations per clone in PBMC ral load in HTLV-I healthy carriers was quite comparable to that found in HTLV-I-infected squirrel monkeys. from inoculated monkey and the inoculum was significantly different. Concerning the variability within each (Angelin-Duclos, in preparation). The differences observed with autologous and homolisolate, two minor hypermutated clones (9-12 mutations leading to 0.28% variability) were found in the PBMC 3 ogous inoculations suggest that squirrel monkeys are more susceptible to infection with HTLV-I homologous weeks after inoculation. These hypermutated clones were not detected 6 months after inoculation (data not cells than in autologous cells (which were given at a 10-fold higher inoculum). In the allogeneic combination, the shown) and the master clone remained the same.
expected strong host response against the foreign major histocompatibility complex (MHC) antigens on the sur-DISCUSSION face of the inoculated cells might facilitate viral infection The results of this study confirm the susceptibility of by providing replicating target lymphocytes in the proximsquirrel monkeys to HTLV-I infection, as first shown by ity of the inoculum. Nakamura et al. (1986) , and extend several virological
In view of the finding that both rabbits (Miyoshi et al., findings. Inoculation of autologous cells resulted in long-1985) and rats (Ibrahim et al., 1994) are infected after term infection in the monkeys, with the HTLV-I provirus inoculation of MT-2 cells, it was striking that the two being present in their PBMC for at least 18 months. There monkeys inoculated with heterologous MT-2 cells failed was no evidence of even transitory disease in these monto seroconvert; HTLV-I provirus was detected in the keys, despite the fact that some were deliberately ex-PBMC of these monkeys 3 weeks after inoculation, but posed to a high dose (10 8 ) of autologous transformed not thereafter. Interestingly it was also reported that cells. A similar situation was observed in rabbits by Akagi sheep can be infected with HTLV-I by inoculation with et al. (1985) and in rats by Yoshiki et al. (1987) , who fresh HTLV-I-infected human PBL, but not with MT-2 cells found that T cells immortalized by HTLV-I in vitro are not (Esteban et al., 1996) . Several explanations are possible tumorigenic in vivo.
for the inefficacy of inoculation by MT-2 cells. First, they It is worth noting that the monkeys inoculated with may have been destroyed by natural antibodies or natural homologous cells responded to the gp46 epitope, reprekiller cells. Second, since MT-2 cells do not carry monkey sented by the MTA1 peptide in the Western blot kit, MHC antigens, they would not provoke an allogeneic whereas those inoculated with autologous cells did not.
response. A third possibility is that the passage of HTLVThis suggests that a high viral load is required to gener-I in squirrel monkey T cells selects a monkey-adapted ate a response to gp46. A similarly selective absence of HTLV-I variant. We thus explored the genetic variability response to gp46 was described in Macaca tonkeana of the gp21 region of HTLV-I provirus in the PBMC of monkeys naturally infected with STLV-I (Ibrahim et al., inoculated monkey compared to the inoculum (homolo-1995), in HTLV-I-infected rats (Ibrahim et al., 1994) and gous cells) and MT-2 cells. As no significant differences in healthy human HTLV-II carriers (Lal et al., 1994) . At were found, there was no evidence of genetic drift, and least in the rat model, the lack of response to gp46 was the mutations present in the monkey PBMC 3 weeks shown to be related to a low viral load (Ibrahim et al.,
after inoculation did not increase with time, the third 1994).
alternative can be ruled out.
The low variability observed in the gp21 region of the The high proviral load of the inoculated monkeys, to-of anti-viral antibody reactivity and detection of virus by gene amplifienv gene may be related to errors arising during PCR cation. Int. J. Cancer 45, [127] [128] [129] [130] amplification. The errors introduced by Taq polymerase Dessutti, C. S., Frazier, D. E., Lafrado, L. J., and Olsen, R. G. (1990). have been found to occur in 1 of 1000 (Pelletier et al., Evaluation of a HTLV-I subunit vaccine in prevention of experimental 1995) or 1 of 3400 (Gessain et al., 1992b) sequenced classes, markers for lymphocyte subsets, and MHC antitype-I in patients with tropical spastic paraparesis. Lancet ii, 407-gens have been characterized (Garraud et al., 1990 (Garraud et al., , 1992 1994). Our study has shown that inoculation of homolo- 
